What's trending

5 most popular innovation stories in Houston this week

From a low-cost ventilator solution coming out of Rice University to can't-miss virtual innovation events, here's what Houston news trended this week. Photo courtesy of Rice University

Editor's note: Another week of COVID-19 lockdown, and Houston's innovation ecosystem continues to rise to the occasion of the challenges resulting from the pandemic. Trending news this week includes an academic team with a way to make low-cost ventilators, virtual events not to miss, and more.

3 Houston innovators to know this week

This week's Houston innovators to know are Megan Eddings, Lance Black, and Todd Burke. Photos courtesy

The city of Houston — much like most major cities in the country — is in crisis mode, with a stay-at-home mandate and rising COVID-19 case numbers.

But these three Houston innovators are emerging as leaders in making masks, discussing the importance of telemedicine at this time, and providing tips on keeping a stable supply chain. Continue reading.

Rice University students and staff team up with Canadian company to make low-cost ventilators

A Houston-based team of scientists and students have developed a low-cost ventilator. Photo courtesy of Rice University

As the COVID-19 case numbers continue to grow, hospitals around the world are either experiencing or expecting a shortage of ventilation units. In Houston, a team of students and staff at Rice University have designed a solution.

Along with Canadian global health design firm, Metric Technologies, the Rice team has developed an automated bag valve mask ventilator that can be crafted for less than $300. Moreover, the team expects to share the designs so that these low-cost machines can be produced everywhere. Continue reading.

4 challenges Houston nonprofits are facing during the COVID-19 crisis — and how they can pivot to stay afloat

Nonprofits are being forced to rethink the way they traditionally reached the community and their donors. Getty Images

As nonprofits struggle to keep funding, staffing, and services afloat during the coronavirus pandemic, Houston organizations are having to get innovative with their fundraising and service to their communities.

My organization, the Easter Seals Greater Houston — which has been a leading provider of services for Veterans, people of all ages with any type of disability and their family members for over seventy years — has decided to pivot its annual Walk With Me fundraiser that is typically held at The Houston Zoo. It's just one of the difficult changes and decisions we are having to make. Here are four things we are keeping in m keep in mind when making a digital pivot as a nonprofit that provides mental health and therapeutic services. Continue reading.

COVID-19 could cost Houston 44,000 jobs by the end of the year, says local economist

According to a new study, Houston is among the cities most vulnerable to job loss due to the recession caused by COVID-19. Getty Images

No matter whether the outlook leans more toward optimism or pessimism, Houston stands to lose a head-spinning number of jobs in the grips of a coronavirus-induced recession.

Economist Bill Gilmer, director of the Institute for Regional Forecasting at the University of Houston's Bauer College of Business, says a moderate recession could drain as many as 44,000 jobs from the regional economy by the end of 2020. That's out of nearly 3.2 million workers in the Houston metro area.

The job figures might look "much worse" through the second and third quarters of this year, Gilmer says. However, he adds, Houston's job losses should be followed by a "quick recovery" in 2021. Continue reading.

10+ can't-miss virtual business and innovation events in Houston for April

Here's what interactive, virtual events to log on to this month. Katleho Seisa/Getty Images

Going into April, the city of Houston has another month at least of working from home, hopping on calls, and setting up video chats — but you don't have to go through this all alone.

Here are over 10 Houston innovation events you can attend virtually via online meetings. Be sure to register in advance, as most will send an access link ahead of the events. Continue reading.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News